We are live on ! Find out more
NLGIA

Nippon Life Global Investors Americas Portfolio holdings

AUM $2.51B
1-Year Est. Return 41.64%
This Fund
S&P 500
This Quarter Est. Return
+15%
1 Year Est. Return
+41.64%
3 Year Est. Return
+173.3%
5 Year Est. Return
+246.87%
10 Year Est. Return
+972.43%
AUM
$1.25B
AUM Growth
+$89M
Cap. Flow
-$64.2M
Cap. Flow %
-5.15%
Top 10 Hldgs %
26.83%
Holding
159
New
17
Increased
36
Reduced
60
Closed
17

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$15.3M
2
ELAN icon
Elanco Animal Health
ELAN
+$14M
3
EQIX icon
Equinix
EQIX
+$12.4M
4
CMG icon
Chipotle Mexican Grill
CMG
+$11.4M
5
EOG icon
EOG Resources
EOG
+$9.51M

Sector Composition

Rank Sector Weight
1 Technology 19.36%
2 Financials 16.28%
3 Healthcare 13.61%
4 Communication Services 10.42%
5 Consumer Discretionary 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
151
Merck
MRK
$328B
-187,215
Closed -$13.7M
MS icon
152
Morgan Stanley
MS
$342B
-223,160
Closed -$8.85M
MTN icon
153
Vail Resorts
MTN
$5.29B
-9,050
Closed -$1.91M
OXY icon
154
Occidental Petroleum
OXY
$58.5B
-58,290
Closed -$3.58M
PEP icon
155
PepsiCo
PEP
$189B
-77,920
Closed -$8.61M
PH icon
156
Parker-Hannifin
PH
$135B
-13,960
Closed -$2.08M
PRGO icon
157
Perrigo
PRGO
$1.76B
-45,850
Closed -$1.78M
SPGI icon
158
S&P Global
SPGI
$121B
-30,100
Closed -$5.11M
CONE
159
DELISTED
CyrusOne Inc Common Stock
CONE
-234,320
Closed -$12.4M

Similar funds

Nippon Life Global Investors Americas's Q1 2019 Portfolio in Review

As of Q1 2019, Nippon Life Global Investors Americas held 159 positions worth $1.25B, up 7.7% from $1.16B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Nippon Life Global Investors Americas withdrew a net $64.2M in Q1 2019, closing 17 positions and reducing 60 holdings. Its most notable exit was Merck, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Nippon Life Global Investors Americas opened a new position in Pfizer worth $15.4M.

  • Nippon Life Global Investors Americas's largest Q1 2019 buy was Pfizer: 381,864 shares worth $15.4M.
  • Nippon Life Global Investors Americas added most to Elanco Animal Health in Q1 2019, an estimated $14M increase.
  • Nippon Life Global Investors Americas's biggest Q1 2019 reduction was Regeneron Pharmaceuticals, cutting an estimated $13.3M.
  • Nippon Life Global Investors Americas fully exited Merck in Q1 2019, selling an estimated $13.7M.
  • Nippon Life Global Investors Americas's ten largest holdings make up 27% of its $1.25B portfolio in Q1 2019.
  • Nippon Life Global Investors Americas opened 17 new positions and closed 17 in Q1 2019.
  • Nippon Life Global Investors Americas's portfolio value rose 7.7% quarter-over-quarter to $1.25B.

Based on Nippon Life Global Investors Americas's 13F filing for Q1 2019, filed 29 Apr 2019.